Rudi Micheletti is a scientist with 10+ years’ experience in cardiovascular epigenome and transcriptome. Rudi holds a doctoral degree from the University of Lausanne (Switzerland) that lead to the discovery of Wisper long non-coding RNA (lncRNA), an activated cardiac fibroblast-specific lncRNA and target of HAYA lead program HTX001. During this period, he contributed to several projects uncovering the functional relevance of other cardiac-associated lncRNAs. Later, Rudi moved to UC San Diego as postdoctoral researcher where he deepened his knowledge of the mechanisms underlying gene transcriptional regulation in cardiac diseases and aging by developing multi-omics state-of-the-art technologies.
At HAYA Therapeutics, Rudi is the Director of Biology and Functional Genomics Unit based in JLABS, San Diego. He and his team contribute to several aspects of HAYA R&D pipeline from target discovery to deep characterization of their molecular function.
His scientific contributions led to several publications accruing more than 900 citations in world-leading, peer-reviewed journals including Nature, Science Translational Medicine and European Heart Journal.